ZEISS establishes the patented SMILE technology with 1.5 million laser vision corrections worldwide
Carl Zeiss Meditec accelerates growth
Carl Zeiss Meditec AG Announces New CFO and Expansion of the Management Board
ZEISS unveils next generation of ophthalmic laser VISULAS green at World Ophthalmology Congress 2018
09/19/2018 - 09/21/2018
Spain, Barcelona
09/19/2018 - 09/21/2018
Italy, Università Politecnica delle Marche - Via Tronto 10/A ANCONA
09/19/2018 - 09/21/2018
United Kingdom, Queen Elizabeth II Conference Centre, Broad Sanctuary, Westminster, London, SW1P 3EE
Carl Zeiss Meditec AG is the parent company of the Carl Zeiss Meditec Group which also includes other subsidiaries. The Group is the focus for most of the medical technology business group's activity within the ZEISS organisation. The company is listed on TecDAX of the German stock exchange.
Find out more on our coporate website.
Carl Zeiss Meditec AG Website
Investor Relations
Diagnosis and treatment of eye diseases, including implants and consumables.
Diagnostic microscopes and solutions for digital visualization for gynecological applications.
Targeted intraoperative radiation therapy for cancer treatments of different tumor diseases.
ZEISS is one of the world’s leading suppliers of medical devices in the field of medical technology. It supplies innovative technologies and application-oriented solutions for ophthalmology and microsurgery designed to help doctors improve the quality of life of their patients.
ZEISS provides complete packages of solutions for diagnosis and devices for optical coherence tomography (OCT), perimetry, optical biometry and slit lamps. For the treatment of eye diseases ZEISS also offers not only ophthalmologic surgical microscopes, but also implants (intraocular lenses | IOLs) and consumables like ophthalmic viscosurgical devices (OVDs).
Within the field of microsurgery ZEISS creates innovative visualization solutions, especially surgical microscopes for minimally invasive surgeries. The medical technology portfolio is rounded off by promising, future-oriented technologies such as intraoperative radiotherapy.
Most of ZEISS’s medical technology activities are combined into Carl Zeiss Meditec AG, which is listed on TecDax of the German stock exchange. For more information, please click here.
